# Effect of Intravenous S-ketamine on Opioid Consumption

> **NCT05060068** · NA · COMPLETED · sponsor: **The Second Hospital of Anhui Medical University** · enrollment: 345 (actual)

## Conditions studied

- Breast Cancer Surgery

## Interventions

- **DRUG:** S-ketamine (low dose)
- **DRUG:** Placebo
- **DRUG:** S-ketamine (high dose)

## Key facts

- **NCT ID:** NCT05060068
- **Lead sponsor:** The Second Hospital of Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-07
- **Primary completion:** 2024-07-07
- **Final completion:** 2024-07-07
- **Target enrollment:** 345 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05060068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05060068, "Effect of Intravenous S-ketamine on Opioid Consumption". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05060068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
